Pilot Program - Current Opportunities
The UNM Clinical & Translational Science Center (CTSC) is soliciting applications from all HSC faculty members– senior as well as junior investigators– in response to the following pilot RFAs.
- Amount: $10,000 to $25,000
- Type of Award: The purpose of this RFA is to support pilot projects that utilize the CTSC infrastructure to produce preliminary data for competitive NIH grant proposals in clinical and translational (T1, T2, T3, and T4) research. Projects must be of high methodological quality and must demonstrate feasible and generalizable solutions to translational research problems.
- Amount: $5,000 to $50,000
- Type of Award: The purpose of this RFA is to support projects that address two or more of the following goals: 1) develop cell-based assays for use in high-throughput screening; 2) to use these cell-based assays for the identification of drugs for clinical repurposing efforts; and, 3) to utilize these previously FDA approved drugs in new clinical trials.
- Amount: $5,000 to $25,000
- Type of Award: The purpose of this RFA is to support innovative, high-risk/high-reward pilot projects to produce preliminary data for competitive NIH proposals in clinical and translational research. Most awards will be expected to seek NIH funding, most likely through an SBIR/STTR mechanism. These projects are intended to provide the preliminary data and initial corporate relationships to develop technology and move it towards successful commercialization.
- Amount: $10,000 to $25,000
- Type of Award: The CTSC, in conjunction with Dialysis Clinic, Inc. (DCI), are soliciting applications for pilot projects that will exemplify the CTSC mission of developing clinical and translational research with an emphasis on kidney disease, hypertension, and/or kidney transplantation. The purpose of this RFA is to support pilot projects that utilize the CTSC infrastructure to produce preliminary data for competitive NIH grant proposals in kidney disease, hypertension, and/or kidney transplantation clinical and translational (T1, T2, T3, and T4) research.
Important Notice Regarding Pilots with Human Subjects Research
Effective August 2015, NIH requires prior approval of all Pilot human subjects research. Applicants will be required to submit an IRB Approval letter along with the approved Protocol and Informed Consent for NIH review. For the October 1st 2017 Funding Cycle, all applicants without IRB submission prior to May 26, 2017 will be administratively disqualified. All applicants must have IRB approval no later than August 4, 2017. Proposals that do not have full IRB approval by this date will not be considered for funding. All applicants who are required to submit an IRB application are strongly encouraged to meet with the CTSC Regulatory Affairs Manager, Sherry Sazesh , for consultation and planning purposes. Please note all IRB protocol titles must match the title of the CTSC pilot application.